NEW YORK (GenomeWeb News) – MDxHealth said today that it has signed up two additional US health insurance providers to cover its prostate cancer test.

Under the agreements, the company's ConfirmMDx for Prostate Cancer test will be covered by HealthSmart, a preferred provider organization network, and Fortified Provider Network.

The company said that with the new agreements more than 135 million people in the US can access the test through their insurance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.